| P-value |
drug |
2 |
1 |
P-values |
| PWM |
drug |
2 |
— |
|
| pyridine |
drug |
4 |
2 |
|
| pyruvate |
drug |
4 |
2 |
|
| Qiagen |
drug |
10 |
2 |
|
| Qiagen DNeasy Blood and Tissue Kit |
drug |
3 |
1 |
DNeasy Blood & Tissue Kit |
| QIMR |
cohort |
9 |
5 |
Australia: QIMR, Australian (QIMR), QIMR cohort, QIMR cohorts, QIMR sample, Queensland Institute of Medical Research |
| QIMR cohort |
cohort |
2 |
2 |
QIMR |
| qPCR |
drug |
5 |
3 |
quantitative PCR |
| quality of life |
phenotype |
9 |
5 |
QOL, QoL, quality of life measure |
| QuantiSNP |
drug |
2 |
2 |
|
| quantitative phenotypes |
phenotype |
6 |
3 |
|
| quantity |
phenotype |
5 |
2 |
quantity of alcohol use, substance use quantity |
| quantity of alcohol consumed |
phenotype |
8 |
3 |
alcohol consumption, patient’s report of quantity of drinking |
| quantity of use |
phenotype |
3 |
1 |
|
| Qubit |
drug |
4 |
— |
|
| Queensland Institute of Medical Research |
cohort |
2 |
— |
QIMR |
| quitting |
phenotype |
2 |
2 |
smoking cessation |
| quitting success |
phenotype |
3 |
3 |
successful quitting |
| QX-314 |
drug |
2 |
1 |
|
